{"entity":{"id":"batea-oncology","kind":"company","name":"Batea Oncology","aka":[],"tldr":"Batea Oncology makes GlioHook, an implant placed in the space left after brain tumour surgery to gather leftover cancer cells in one place and make them more sensitive to radiotherapy. It is in a first small study in people with suspected high-grade glioma.","summary":"Batea Oncology S.L., of Santiago de Compostela, A Coruna, Spain, develops GlioHook, which it describes as a class III medical device for glioblastoma. Implanted to cover the resection margins after surgery, it is designed to concentrate residual tumour cells in a controlled location, turning an infiltrative disease into a focal one, and to sensitise those cells to radiotherapy. A prospective, multicentre, single-arm pilot investigation (NCT07725640) plans to enrol 15 patients with suspected high-grade glioma at sites in Barcelona, Madrid and Santiago de Compostela, with Apices Soluciones listed as collaborator. Its first registered cancer trial, NCT07725640, was posted on ClinicalTrials.gov in July 2026.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://bateaoncology.com/"},{"label":"Legal notice with registry details","url":"https://bateaoncology.com/legal-notice/"},{"label":"ClinicalTrials.gov: GlioHook pilot investigation (NCT07725640)","url":"https://clinicaltrials.gov/study/NCT07725640"}],"tags":[],"related":[],"cancers":["glioblastoma","brain-tumours"],"sections":["devices","surgery"],"technologies":["radiosensitisers"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Founding year not stated as such; the company's legal notice gives a first commercial registry entry in A Coruna dated 17 July 2024, read on 29 October 2026.","No financing or results have been read.","The trial record was posted on 24 July 2026 with a planned start of 30 October 2026."],"hq":"Santiago de Compostela","country":"ES","companyType":"devices","website":"https://bateaoncology.com/","stage":"startup","investors":[],"funding":[]},"route":"/companies/batea-oncology/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"section":[{"id":"devices","kind":"section","name":"Devices & Physical Therapies","route":"/fronts/devices/"},{"id":"surgery","kind":"section","name":"Surgery & Interventional","route":"/fronts/surgery/"}],"technology":[{"id":"radiosensitisers","kind":"technology","name":"Radiosensitisers","route":"/technologies/radiosensitisers/"}]}}